Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 17
- No 13F data for Q4 2020
- Portfolio value
- $289.6M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PCVXVaxcyte, Inc. | COM | 4,168,718 | $82.1M | 28.4% | – | – | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,203,135 | $45.1M | 15.6% | – | – | History |
| Spruce BioE5209E109 | Common | 1,792,518 | $29.7M | 10.3% | – | – | – |
| ACETAdicet Bio, Inc. | COM | 1,615,385 | $21.0M | 7.2% | – | – | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,499 | $20.3M | 7.0% | – | – | History |
| SIENProject Sage Oldco, Inc. | COM | 2,390,843 | $17.4M | 6.0% | – | – | History |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $16.6M | 5.7% | – | – | History |
| XCURExicure, Inc. | COM | 6,977,000 | $15.1M | 5.2% | – | – | History |
| SRRASierra Oncology, Inc. | COM | 871,125 | $14.7M | 5.1% | – | – | History |
| SLNOSoleno Therapeutics Inc | COM NEW | 10,302,602 | $13.0M | 4.5% | – | – | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $7.33M | 2.5% | – | – | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $2.51M | 0.9% | – | – | History |
| XFORX4 Pharmaceuticals, Inc | COM | 229,885 | $1.96M | 0.7% | – | – | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $1.90M | 0.7% | – | – | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $595.0K | 0.2% | – | – | History |
| OBSVObsEva SA | COM | 87,999 | $286.0K | 0.1% | – | – | History |
| OCGNOcugen, Inc. | Common | 7,111 | $48.0K | <0.1% | – | – | History |